HTGC logo

Hercules Capital Inc. (HTGC)

$15.63

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on HTGC

Market cap

$2.96B

EPS

1.88

P/E ratio

8.1

Price to sales

6.34

Dividend yield

10.237%

Beta

0.823858

Price on HTGC

Previous close

$15.77

Today's open

$15.80

Day's range

$15.63 - $15.86

52 week range

$13.70 - $19.13

Profile about HTGC

CEO

Scott Bluestein

Employees

100

Headquarters

San Mateo, CA

Exchange

New York Stock Exchange

Shares outstanding

189548796

Issue type

Common Stock

HTGC industries and sectors

Finance

Asset Management Services

News on HTGC

Hercules Capital Surpasses $4.0 Billion in Annual Debt and Equity Commitments for First Time in History

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it, together with its private funds managed by its adviser subsidiary, have originated more than $4.0 billion in annual total debt and equity commi.

news source

Business Wire • Nov 17, 2026

news preview

Hercules Capital: Accumulation Opportunity At 15% Below Historical P/NAV

Hercules Capital remains a top-tier BDC, outperforming peers in net investment income growth, portfolio expansion, and balance sheet quality. HTGC benefits from positive interest rate sensitivity, with 97.9% of its portfolio in variable-rate loans, positioning it for further NII upside. Despite trading at a premium, HTGC's current P/NAV is ~15% below its 3-year average, offering an attractive entry for income-focused investors.

news source

Seeking Alpha • Nov 13, 2026

news preview

11%+ Yields That Are Not Yield Traps

Dividend yields above 11% typically signal significant risks, but occasionally the market offers opportunities to collect exceptionally high income without taking on excessive risk. Strong balance sheets, conservative underlying asset structuring, and proven track records can help protect double-digit dividend payouts. I discuss two compelling income opportunities offering approximately 11% to 12% yields, explain their dividend coverage and risks, and assess why they could deliver attractive long-term total returns.

news source

Seeking Alpha • Nov 12, 2026

news preview

2 Elite Income Machines: 9-11% Yields

High yields combined with quality enterprises can be a winning combination. In this article, I highlight two such names that offer the best of both worlds. Both have durable track records of dividends and a robust outlook.

news source

Seeking Alpha • Nov 11, 2026

news preview

Atea Pharmaceuticals Secures Credit Facility for Up to $200 Million from Hercules Capital

BOSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it has entered into a credit facility agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to $200 million. The facility strengthens Atea's financial position and provides strategic and operational flexibility as the Company expands its commercial-related activities in anticipation of the product launch of the regimen of bemnifosbuvir/ruzasvir (BEM/RZR) in the United States (US) for the treatment of chronic hepatitis C virus (HCV), if approved, and advances the Company's clinical program for hepatitis E virus (HEV).

news source

GlobeNewsWire • Nov 9, 2026

news preview

Hercules Capital: Earnings Lower, But Credit Holds, Still A Buy

Hercules Capital remains a Buy, but with lower conviction than in August, as fundamentals are clean but per-share NII growth is lacking. Credit quality is strong, with non-accruals minimal and internal grades improving, though leverage increased due to slower repayments. The income stream is steady; Q3 NII was $0.47 per share, down from $0.50 in Q2, mainly due to lower prepayments and higher debt costs.

news source

Seeking Alpha • Nov 5, 2026

news preview

Hercules Capital: The Premium Is Still Justified After A Decent Q3

Hercules Capital earns a 'Buy' rating, with a resilient NAV, strong dividend coverage, and sector-leading ROE despite a slow quarter. HTGC trades at a 1.35x NAV premium, justified by 13% annualized ROE and superior credit quality versus peers, with minimal non-accruals. Dividend coverage remains robust at 117% in Q3, with supplemental dividends likely to continue as portfolio growth and income durability persist.

news source

Seeking Alpha • Nov 4, 2026

news preview

Hercules Capital: Upgrading To A Buy As Rate Hikes Now Cover Refinancing

I am upgrading Hercules Capital to buy and raising my price target from $15.38 to $16.43, with a full dividend yield of $1.88 on top. HTGC's Q3 NII of $0.47 per share was better than it looks, at $0.485 after adjusting for lower-than-expected early repayments. The loan book expanded by $252.9 million, primarily funded by borrowings, signaling robust portfolio growth.

news source

Seeking Alpha • Nov 2, 2026

news preview

Hercules Capital Q3 Earnings Call Highlights

Hercules Capital NYSE: HTGC reported third-quarter 2026 results marked by record year-to-date originations, portfolio growth and stable credit quality, while management said it expects higher investment income and net investment income in the fourth quarter as loan prepayments normalize.

news source

MarketBeat • Oct 30, 2026

news preview

Hercules Capital, Inc. (HTGC) Q3 2026 Earnings Call Transcript

Hercules Capital, Inc. (HTGC) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Oct 30, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Hercules Capital Inc.

Open an M1 investment account to buy and sell Hercules Capital Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in HTGC on M1